MIBG Therapy for Neuroblastoma: Precision Achieved With Dosimetry, and Concern for False Responders

Neuroblastoma causes 15% of cancer mortality in children. High risk neuroblastoma has poor prognosis, with high relapse rate and mortality despite multimodal treatment. 123-I-meta-iodo-benzyl-guanidine (mIBG) scintigraphy is one of the current standard diagnostic procedures in neuroblastoma. mIBG ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Rubio, Pedro M., Galán, Victor, Rodado, Sonia, Plaza, Diego, Martínez, Leopoldo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270400/
https://www.ncbi.nlm.nih.gov/pubmed/32549040
http://dx.doi.org/10.3389/fmed.2020.00173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270400/
https://www.ncbi.nlm.nih.gov/pubmed/32549040
http://dx.doi.org/10.3389/fmed.2020.00173

Ejemplares similares